Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA as effective as sumatriptan in treatment of acute migraines
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Pain Managers and Prescribers
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
961 The Pharmacokinetics, Pharmacodynamics, and Tolerability of Liraglutide, a Once-Daily Human GLP-1 Analogue, After Multiple Subcutaneous Administration in Healthy Chinese Male Subjects The Journal of Clinical Pharmacology, February 11, 2011
962 Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers: A Randomized, Open-Label, Two-Period, Parallel-Group, Crossover Study Clinical Drug Investigation, February 11, 2011
963 Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium Full Text Journal of Clinical Oncology, February 10, 2011 Clinical Article
964 Lopinavir/Ritonavir Population Pharmacokinetics in Neonates and Infants British Journal of Clinical Pharmacology, February 10, 2011
965 Pharmacokinetics of ropivacaine in patients with chronic renal failure Full Text British Journal of Anesthesia, February 10, 2011
966 The Pharmacokinetics, Pharmacodynamics, and Tolerability of Liraglutide, a Once-Daily Human GLP-1 Analogue, After Multiple Subcutaneous Administration in Healthy Chinese Male Subjects The Journal of Clinical Pharmacology, February 10, 2011
967 N-acetylcysteine as a Novel Prophylactic Treatment for Ifosfamide-Induced Nephrotoxicity in Children: Translational Pharmacokinetics The Journal of Clinical Pharmacology, February 10, 2011
968 Model-Based Evaluation of Similarity in Pharmacokinetics of Two Formulations of the Blood-Derived Plasma Product C1 Esterase Inhibitor The Journal of Clinical Pharmacology, February 9, 2011
969 A Review of Psychophysiological Stressors on Pharmacokinetics The Journal of Clinical Pharmacology, February 9, 2011
970 Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go The Journal of Clinical Pharmacology, February 9, 2011
971 Absence of Pharmacokinetic Interaction Between Roflumilast and Digoxin in Healthy Adults The Journal of Clinical Pharmacology, February 9, 2011
972 The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers The Journal of Clinical Pharmacology, February 9, 2011
973 Pharmacokinetic Optimization of Antiretroviral Therapy in Children and Adolescents Clinical Pharmacokinetics, February 8, 2011
974 Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients Clinical Pharmacokinetics, February 8, 2011
975 Development of 41Ca-Based Pharmacokinetic Model for the Study of Bone Remodelling in Humans Clinical Pharmacokinetics, February 8, 2011
976 Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma European Journal of Clinical Pharmacology, February 7, 2011
977 Pharmacokinetics of Sotrastaurin Combined With Tacrolimus or Mycophenolic Acid in De Novo Kidney Transplant Recipients Transplantation, February 7, 2011 Clinical Article
978 Teva Files Petition Surrounding Generic Copaxone Full Text U.S. Pharmacist, February 7, 2011
979 Association of GSTM1 null polymorphism with isosorbide-5-mononitrate cardiovascular response and involvement of CGRP in healthy Chinese male volunteers Pharmacogenetics and genomics, February 7, 2011
980 Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer Full Text BMC Pharmacology & Toxicology, February 4, 2011
1 Anticoagulation revolution: Optimizing care from all angles American Pharmacists Association News, April 5, 2013 Free full text
2 Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects International Journal of Antimicrobial Agents, April 29, 2013
3 Validation of a Novel Approach for Dose Individualization in Pharmacotherapy Using Gabapentin in a Proof of Principles Study Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 8, 2013
4 Pharmacokinetic studies of protein drugs: Past, present and future Advanced Drug Delivery Reviews, April 3, 2013 Review Article
5 A review on estimation of stochastic differential equations for pharmacokinetic/pharmacodynamic models Advanced Drug Delivery Reviews, April 3, 2013 Review Article
6 Drug–Alcohol Interactions American Journal of Lifestyle Medicine, April 11, 2013 Review Article
7 Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived Products American Journal of Therapeutics, April 9, 2013 Review Article
8 Antifungal therapy: current concepts and evidence-based management Current Medical Research and Opinion, March 4, 2013 Review Article
9 Pharmacokinetics of Doripenem in Infected Patients Treated Within and Outside the Intensive Care Unit Annals of Pharmacotherapy, April 22, 2013
10 Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents Clinical Microbiology Reviews, April 4, 2013
11 Population Pharmacokinetic Analysis of Colistin in Burn Patients Antimicrobial Agents and Chemotherapy, April 18, 2013
12 Population pharmacokinetic of antiepileptic drugs in different populations Central European Journal of Medicine, April 11, 2013
13 Gentamicin Pharmacokinetics and Dosing in Neonates with Hypoxic Ischemic Encephalopathy Receiving Hypothermia Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 2, 2013
14 Prescription Opioid Abuse in the United Kingdom British Journal of Clinical Pharmacology, April 26, 2013
15 The population pharmacokinetics of allopurinol and oxypurinol in patients with gout European Journal of Clinical Pharmacology, March 19, 2013
16 Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! European Journal of Clinical Pharmacology, April 25, 2013
17 Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation Journal of Pharmacology and Experimental Therapeutics, January 14, 2013
18 A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers Epilepsy Research, April 16, 2013
19 Metabolism and Pharmacokinetics of Novel Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor Apatinib in Humans Drug Metabolism and Disposition, April 1, 2013
20 Dose finding by concentration-response versus dose-response: a simulation-based comparison European Journal of Clinical Pharmacology, February 21, 2013 Review Article
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close